Registry of Lobbyists
Total Number of Communication Reports: 9
Monthly communication reports in the last 6 months: 0
Version 1 of 9 (1999-02-12 to 2000-02-29) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
LEO PHARMA INC.
555 KINGSTON ROAD WEST AJAX, ON L1S 6M1 Canada |
| Telephone number: | 905-427-8828 |
| Fax number: | 905-427-8161 |
| Responsible officer name and position during the period of this registration: | GREGORY C HINES, PRESIDENT |
| Description of activities: | MY EMPLOYER IS A BRAND NAME PHARMACEUTICAL MANUFACTURER (PRESCRIPTION DRUGS). |
| Parent: | The corporation is not a subsidiary of any other parent corporations. |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Canadian International Trade Tribunal (CITT), Finance Canada (FIN), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, National Research Council (NRC), Patented Medicine Prices Review Board (PMPRB), Treasury Board Of Canada Secretariat (TBS) |
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format |
| Subject Matter: Areas of Concern: | PHARMACEUTICALS |
| Subject Matter: Particulars: | LEGISLATIVE PROPOSALS:PATENT ACT REGULATIONS: HPB: BUREAU OF PRESCRIPTION DRUGS, NEW DRUG LICENSING PRACTICES PATENTED MEDICINE PRICES REVIEW BOARD, HOME PHARMA CARE, LINKAGE REEGULATIONS |